Miriam E. Tucker

Language matters when interacting with patients who have conditions such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and dysautonomia.

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in people with obesity.

Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID algorithm technology approval in the United States for people with type 2 diabetes.

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often encounter barriers in obtaining insulin.

In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.

Sanofi-Aventis’ Merilog works the same way as Novo Nordisk’s Novolog.

Seven rheumatology researchers have authored a paper questioning the utility of the 2024 National Academies’ broad definition of long COVID.

The European Association for the Study of Obesity and the Obesity Medicine Association expressed concerns about the Lancet Commission report, particularly about the “preclinical” obesity designation.

Changes or updates to hardware or software can result in loss of alerts.

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with chronic kidney disease.